A scientist is using AI to design a nasal spray that could protect us from the flu, COVID, and colds
A researcher is working on a nasal spray to protect against COVID-19. He thinks a similar tool could protect against the flu and colds as well.
Sarah Braner
Healthcare Fellow
3 statistics that show how quickly one of the hottest areas of healthcare plunged into a downturn
Funding for digital health surged in 2021 amid the coronavirus pandemic, but it suffered a big downturn in 2022.
The billionaire CEO of a top biotech VC firm details how a new type of AI could transform how we test and discover treatments
Artificial intelligence has the potential to make possible new therapeutics, drugs, and tests, Flagship Pioneering CEO Noubar Afeyan said.
The stock of psychedelics giant Atai is tumbling after a treatment failed to help patients in a trial
Atai Life Sciences' ketamine-based therapy failed to help patients with depression in a mid-stage trial.
Walgreens and CVS say they plan to sell abortion pills after an FDA rule change
Retail pharmacies can start dispensing the abortion pill after an FDA ruling, expanding access to reproductive healthcare.
Brazilian soccer legend Pelé died of colon cancer. Here are the cutting-edge clinical trials trying to find new treatments for the disease.
Pelé, a legendary Brazilian soccer player, died of colon cancer. These clinical trials are studying new treatments for the disease.
A new cholera outbreak is killing hundreds in Haiti. Scientists think it's the same strain that was brought to the country by UN troops more than a decade ago.
The current strain of cholera fueling an outbreak in Haiti is likely related to the strain that caused the 2010 outbreak, according to scientists.
Meet Prenuvo, a company that says its $2,500 full-body MRI scan can detect the earliest stages of disease. Experts say it could do more harm than good.
Prenuvo offers full-body MRI scans to help find diseases early. Experts say you probably don't need one — and that it could do more harm than good.
NYU's emergency room gave special treatment to donors and VIPs including Chuck Schumer, report says
NYU Langone gave VIPs, such as trustees and donors, preferential treatment while others waited, according to a report from The New York Times.
The US is releasing doses of flu medicine from the national stockpile amid a surge in cases
Flu season continues to thrash the US. The government is now allowing states to access the national stockpile of Tamiflu to cope.
A tiny biotech's experimental treatment for a silent disease that strikes millions just cleared a key hurdle and the stock is up more than 200%
Madrigal Pharmaceuticals reported positive results for its treatment for NASH. It hopes to file for FDA approval in 2023.
33 healthcare and biotech startups investors expect to take off in 2023
We asked investors to name the startups poised for success in a tough market, from young upstarts to companies on the brink of going public.
Strep A is surging in the UK and has already killed at least 19 children. Here's why it's taken so long to make a vaccine against this deadly pathogen.
Some researchers are working on a strep-A vaccine, but it will be a long time before one is available.
A new wave of companies is making testosterone easily available online. The authors of a recent study say there could be risks to patients.
A new study says that direct-to-consumer companies may not be educating patients about the risks of testosterone.
20 years ago, a Lyme-disease vaccine was taken off the market. Now, 2 companies are developing one that could be available by 2025.
Pfizer and Valneva have said their vaccine produced immunity in phase 2 trials. If phase 3 pans out, they may have the first Lyme vaccine in 20 years.
An early-stage HIV vaccine is showing positive results. If it works, it would be first successful HIV vaccine after almost 40 years of research.
An early study found that recipients of an experimental HIV vaccine showed immune system activity. It could be a cause for hope in the long-running effort to find a vaccine.
100-hour workweeks and a bit of luck: How a 25-year-old CEO raised $50 million for his new drug discovery startup
Laksh Aithani founded one of biotech's hottest startups. The first-time CEO shared how he jumped from college student to biotech exec.
A biotech investor says founders should be 'more relentless than ever' when trying to raise funds during the current market downturn
The economic slowdown is making it harder for biotech founders to raise money. An investor says founders should be creative and aggressive when trying to raise more capital.
Billionaire investor Vinod Khosla lays out why changing how primary care is paid for could disrupt healthcare
Vinod Kholsa said primary care and AI both had major roles to play in reducing healthcare costs. Here's how he thinks it could work.
Meet the 16 pioneering biotech VCs who are taking new approaches to investing and reshaping the industry's future
These 16 biotech investors are all in their first decade of working in venture capital and bringing fresh perspectives to the world of biotech.